Jump to content

Problem:Cardiovascular risk reduction in obesity

From Pharmacopedia
Revision as of 04:02, 23 May 2026 by MDElliottMD (talk | contribs) (Auto-create stub from pcp_problem migration)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Stub. A short clinical description of Cardiovascular risk reduction in obesity goes here.

Reduction of MACE in adults with obesity but without type 2 diabetes (SELECT trial indication).

Medicines used for Cardiovascular risk reduction in obesity

Retrieved from "https://pharmacopedia.wiki/index.php?title=Problem:Cardiovascular_risk_reduction_in_obesity&oldid=5977"